It is called a targeted therapy because it particularly targets the CD38 that are overexpressed within the multiple myeloma cells. Daratumumab is from a class of medicines referred to as CD38 monoclonal antibodies. J codes are very important, accurate, and consistent coding for billing and reimbursement applications. J codes are https://adhdozempic.com/